← Eichor
Condition: Antisynthetase Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antisynthetase Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Descartes-08 in Autoantibody Myositis
Phase 2 · 2 location(s) · Cartesian Therapeutics · NCT07391605Optimizing Treatment on Idiopathic Inflammatory Myopathies
Phase N/A · 1 location(s) · University of Sao Paulo · NCT03092180Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease
Phase N/A · 6 location(s) · Central Hospital, Nancy, France · NCT05984394BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy
Phase 1 · 1 location(s) · iCell Gene Therapeutics · NCT07715136An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and
EARLY_Phase 1 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06613490A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial L
NA · 1 location(s) · China-Japan Friendship Hospital · NCT07406932
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.